Chemotherapy in Pregnancy: Assessing the Safety of Adriamycin Administration in Pregnancy Complicated by Breast Cancer

Priyanshu Nain, Lakshya Seth, Ashley Shawn Bell, Priyanka Raval, Gyanendra Sharma, Monique Bethel, Garima Sharma, Avirup Guha

Research output: Contribution to journalArticlepeer-review

Abstract

Pregnancy-associated breast cancer is challenging to treat. Treatment with chemotherapeutic agents such as anthracyclines poses a risk of cardiotoxicity, despite being considered safe after the second trimester of pregnancy. Management requires multidisciplinary comanagement with cardio-obstetrics, cardiology-oncology, maternal-fetal medicine, and oncology.

Original languageEnglish (US)
Article number102141
JournalJACC: Case Reports
Volume28
DOIs
StatePublished - Dec 20 2023

Keywords

  • cancer
  • cardiomyopathy
  • pregnancy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Chemotherapy in Pregnancy: Assessing the Safety of Adriamycin Administration in Pregnancy Complicated by Breast Cancer'. Together they form a unique fingerprint.

Cite this